AzTrials
AzTrials

Post-Traumatic Stress Disorder ComplexEVALINCT06535243

Evaluation of the Efficacy of "Lifespan Integration" (LI) Therapy in Patients With Complex Post-Traumatic Stress Disorder

A study testing Lifespan Integration Therapy (LI) in people with Post-Traumatic Stress Disorder Complex and Psychiatric Disorder, run by Centre Hospitalier St Anne at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The study aims to evaluate the efficacy of a relatively new type of psychotherapy called Lifespan Integration (LI) in patients suffering of complex PTSD Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Lifespan Integration Therapy (LI)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
38 participants
Where
1 siteFrance
Study dates
1 Apr 2024to 1 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients diagnosed with complex PTSD
  • French speaking
  • first time following an LI type of therapy
  • psychotropic treatment is allowed

Who cannot join

  • no other parallel psychotherapy is accepted (if the patient underwent recently any other type of psychotherapy, a "wash out " period of minimum 4 weeks is required )
  • no active manic episode at the time of inclusion
  • no active psychotic episode at the time of inclusion
  • no chronic psychotic disorder diagnosis
  • no autistic spectrum disorder diagnosis ,
  • no intellectual deficit

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • CHU St Anne

    Paris, Île-de-France Region, 75014

    Alexandru GAMAN, MD, +33658981274, a.gaman@ghu-paris.fr

    Recruiting

Other trials in France

About this study

Official title: Evaluation of the Efficacy of "Lifespan Integration" Therapy in Patients With Complex Post-Traumatic Stress Disorder

The study aims to evaluate the efficacy of a relatively new type of psychotherapy called Lifespan Integration (LI) in patients suffering of complex PTSD

Being tested
Lifespan Integration Therapy (LI)
Keywords
Lifespan Integration Therapy, Psychotrauma type II, Abuse, Victims, Complex Post-traumatic Stress Disorder, Psychotherapy
Medical subject headings
Mental Disorders, Coitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lifespan Integration Therapy (LI)Behavioural

    same as above

Study groups in NCT06535243
Study groupRoleWhat they receive
LI TherapyExperimentalLI Therapy will be delivered in two recruiting centers by experienced LI Therapy trained psychologists or psychiatrists (a minimum level three of training is required) The intervention will consist in delivering 15 "Basic" Protocol therapy sessions targeting symptoms of complex PTSD The study contains one single arm. One extra-session called PTSD protocol could be optionally delivered if the patient had a very recent trauma that could exacerbate his PTSD symptoms. This session is delivered in the beginning of the research protocol.
Receives: Behavioral: Lifespan Integration Therapy (LI)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change of the scores of International Trauma Questionnaire

    International Trauma Questionnaire measures subscores of simple and complex PTSD, the score is calculated using an algorithm, a minimum score of 8 for the PTSD simple part and of 8 for PTSD complex part is needed in order to diagnose a complex PTSD; the maximum score for simple PTSD is 16, same for complex PTSD.

    Measured: maximum one year

Secondary outcomes (1)
  1. Difficulties in Emotion Regulation Scale (DERS) Score

    the DERS scale (Gratz and Roemer, 2004) contains 36 Likert Scale questions with scores from 1 to 5; the scale can generate a total score and six underscores (assessing nonacceptance, goals, impulse, awareness, strategies, clarity); in a general population cohort the mean score was of 77.99 (SD= 20.72) for N=260 women and 80.66 (SD= 18.79) for N=97 men

    Measured: maximum one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2024
  2. Study start1 Apr 2024
  3. Primary completion1 Apr 2027 (estimated)
  4. Study completion1 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
eligible candidates to be included in this cohort should be * older than 18 yo * French speaking * with a diagnosis of complex PTSD as confirmed by 1/clinical interview with a trained psychiatrist and 2/ scores for the International Trauma Questionnaire (ITQ), clinical tool based on the ICM 11 criteria
Masking
None (open label)
Enrolment
38 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06535243
Sponsor's protocol ID
D21-P019
Acronym
EVALI
Status last verified
Aug 2024
First submitted
28 Apr 2024
Last updated
2 Aug 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Lifespan Integration Therapy (LI) in people with Post-Traumatic Stress Disorder Complex and Psychiatric Disorder, run by Centre Hospitalier St Anne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hayat OUATAH (+331 45 65 84 86, hayat.ouatah@ghu-paris.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change of the scores of International Trauma Questionnaire (time frame: maximum one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in